Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Macular ischaemia after intravitreal bevacizumab injection in patients with central retinal vein occlusion and a history of diabetes and vascular disease.

× No keyword cloud information.

19 in total

1. Intravitreal bevacizumab for severe vaso-occlusive retinopathy in systemic lupus erythematosus.

Authors: Won June Lee; Hee Yoon Cho; Yoon Jung Lee; Byung Ro Lee; Jae Pil Shin
Journal: Rheumatol Int Date: 2011-09-28 Impact factor: 2.631

2. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy.

Authors: Osama A Sorour; Almyr S Sabrosa; A Yasin Alibhai; Malvika Arya; Akihiro Ishibazawa; Andre J Witkin; Caroline R Baumal; Jay S Duker; Nadia K Waheed
Journal: Int Ophthalmol Date: 2019-05-22 Impact factor: 2.031

3. Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema: A Subanalysis of the RESTORE (Extension) Study.

Authors: Sonja G Karst; Gabor G Deak; Bianca S Gerendas; Sebastian M Waldstein; Jan Lammer; Christian Simader; Tadhg Guerin; Ursula M Schmidt-Erfurth
Journal: JAMA Ophthalmol Date: 2018-04-01 Impact factor: 7.389

4. Implantable MicroPump for Drug Delivery in Patients with Diabetic Macular Edema.

Authors: Mark Humayun; Arturo Santos; Juan Carlos Altamirano; Ramiro Ribeiro; Roberto Gonzalez; Alejandro de la Rosa; Jason Shih; Changling Pang; Fukang Jiang; Philip Calvillo; John Huculak; Jenna Zimmerman; Sean Caffey
Journal: Transl Vis Sci Technol Date: 2014-12-01 Impact factor: 3.283

5. Ocular microcirculation changes, measured with laser speckle flowgraphy and optical coherence tomography angiography, in branch retinal vein occlusion with macular edema treated by ranibizumab.

Authors: Toshifumi Asano; Hiroshi Kunikata; Masayuki Yasuda; Koji M Nishiguchi; Toshiaki Abe; Toru Nakazawa
Journal: Int Ophthalmol Date: 2020-09-07 Impact factor: 2.031

6. Effect of intravitreal bevacizumab on vascular endothelial growth factor expression in patients with proliferative diabetic retinopathy.

Authors: Eun Jee Chung; Shin Jeong Kang; Ja Seung Koo; Yoon Jung Choi; Hans E Grossniklaus; Hyoung Jun Koh
Journal: Yonsei Med J Date: 2011-01 Impact factor: 2.759

7. Insight into 144 patients with ocular vascular events during VEGF antagonist injections.

Authors: Ahmad M Mansour; Maha Shahin; Peter K Kofoed; Maurizio B Parodi; Michel Shami; Stephen G Schwartz
Journal: Clin Ophthalmol Date: 2012-03-06

8. Polypoidal choroidal vasculopathy in a case of retinitis pigmentosa, successfully treated with intravitreal aflibercept.

Authors: Nana Takahashi; Hiroshi Kunikata; Masayuki Yasuda; Takehiro Hariya; Koji M Nishiguchi; Toru Nakazawa
Journal: Am J Ophthalmol Case Rep Date: 2021-05-24

9. Retinal ganglion cell function after repeated intravitreal injections of ranibizumab in patients with age-related macular degeneration.

Authors: Tomoharu Nishimura; Shigeki Machida; Tomomi Harada; Daijiro Kurosaka
Journal: Clin Ophthalmol Date: 2012-07-13

10. Accelerated ischemic vascular retinopathy after intravitreally injected bevacizumab for central retinal vein occlusion in elderly patients.

Authors: Vincenzo Isola; Alfredo Pece; Claudio Massironi; Simone Reposi; Fabio Dimastrogiovanni
Journal: Clin Ophthalmol Date: 2013-03-01